NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Operating Margin in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Operating Margin history and growth rate from Q3 2021 to Q2 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Operating Margin for the quarter ending June 30, 2024 was -312 %, a 60.8% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Operating Margin for 2023 was -612 %, a 89.6% increase from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Operating Margin for 2022 was -5.86K %, a 2.17% decline from 2021.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Operating Margin for 2021 was -5.74K %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -312 +485 +60.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -348 +1.04K +74.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -482 +3.09K +86.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -612 +5.25K +89.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -796 +6.68K +89.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.39K +5.89K +81% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.57K +4.18K +53.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -5.86K -124 -2.17% Jul 1, 2022 Sep 30, 2022
Q2 2022 -7.48K Apr 1, 2022 Jun 30, 2022
Q1 2022 -7.27K Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.75K Oct 1, 2021 Dec 31, 2021
Q3 2021 -5.74K Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.